Il-Kang Na

6PUBLICATIONS
66CO-AUTHORS
Haematological tumoursPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 06, 2026
Clonal hematopoiesis and lymphoma-associated mutations in hematopoietic progenitors in B-cell non-Hodgkin lymphoma.

Laura Wiegand, Patricia Silva, Daniel Noerenberg

|May 21, 2025
CD8+ T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells.

Phillip Schiele, Alberto Sada Japp, Regina Stark

|Jul 23, 2024
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth.

Kamila Pulawska-Moon, Donata Ponikwicka-Tyszko, Weronika Lebiedzinska

|Mar 22, 2024
Comparable CD8+ T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals.

Eva Tranter, Marco Frentsch, Marie Luise Hütter-Krönke

|Apr 05, 2023
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).

Arndt Stahler, Beeke Hoppe, Il-Kang Na

|Feb 18, 2021
Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges.

Stefanie Herda, Andreas Heimann, Benedikt Obermayer

Pageof 1

Frequent Collaborators

2 joint publications

Marco Frentsch

2 joint publications

Slawomir Wolczynski

2 joint publications

Phillip Schiele

2 joint publications

Nafis A Rahman